Aigen Investment Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-4,538	Closed	-$2.07M	–	568
2025 Q3	$2.07M	Buy	+4,538	New	+$1.85M	0.32%	63
2025 Q1	–	Sell	-2,606	Closed	-$613K	–	742
2024 Q4	$613K	Buy	+2,606	New	+$685K	0.11%	277
2024 Q2	–	Sell	-2,827	Closed	-$422K	–	750
2024 Q1	$422K	Sell	2,827 -21,717	-88%	-$3.62M	0.09%	328
2023 Q4	$4.7M	Buy	+24,544	New	+$4.18M	0.84%	7
2023 Q3	–	Sell	-26,604	Closed	-$5.05M	–	803
2023 Q2	$5.05M	Buy	26,604 +11,978	+82%	+$2.37M	0.75%	14
2023 Q1	$2.93M	Buy	14,626 +7,767	+113%	+$1.63M	0.4%	60
2022 Q4	$1.63M	Buy	6,859 +4,936	+257%	+$1.05M	0.23%	123
2022 Q3	$385K	Buy	+1,923	New	+$367K	0.06%	356
2022 Q2	–	Sell	-3,420	Closed	-$558K	–	515
2022 Q1	$558K	Buy	+3,420	New	+$521K	0.1%	264
2021 Q3	–	Sell	-3,283	Closed	-$557K	–	459
2021 Q2	$557K	Buy	+3,283	New	+$481K	0.1%	217